Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
17 18 Next >
Watson Announces Pricing of Secondary Offering By Selling Stockholder
November 11, 2010
from PR Newswire
Watson Announces Commencement of Secondary Offering by Selling Stockholder
November 10, 2010
from PR Newswire
Watson Announces Top Line Uracyst® U.S. Pilot Study Results
November 10, 2010
from PR Newswire
Stellar Pharmaceuticals Provides Update on Watson's U.S. Pilot Study of Uracyst(R)
November 10, 2010
from Marketwired News Releases
Watson’s Eden Biodesign and Crucell Sign Vendor Network Agreement Facilitating Access to cGMP Manufacturing Services for Vaccines and Gene Therapies Using PER.C6® Cell Line Technology
November 10, 2010
from Business Wire News Releases
Watson Q3 Net Revenue Climbs 33 Percent to $882 Million
November 04, 2010
- Third Quarter Adjusted Cash EPS of $0.85 Read More
from PR Newswire
Watson Signs Exclusive Agreement to Distribute Authorized Generic Concerta®
November 02, 2010
from PR Newswire
Watson To Present At The 2010 Credit Suisse Healthcare Conference
October 29, 2010
from PR Newswire
Watson Confirms Crestor® Patent Challenge
October 27, 2010
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Equity Research on Mylan Inc. and Watson Pharmaceuticals Inc. - Generic Drug Makers Looking Good
October 19, 2010
from Marketwired News Releases
Watson's Generic Version of Lotrel ® Receives FDA Approval
October 15, 2010
from PR Newswire
Critical Alerts for AIG, SanDisk, Diamond Offshore Drilling, Watson Pharmaceuticals, and Aon Released by Seven Summits Research
October 13, 2010
from PR Newswire
Watson to Host Conference Call and Webcast to Discuss Third Quarter 2010 Earnings
October 12, 2010
from PR Newswire
Columbia Laboratories Announces USPTO Notice of Allowance for Key Progesterone Preterm Birth Patent
October 12, 2010
from Business Wire News Releases
Columbia Laboratories Announces USPTO Notice of Allowance for Key Progesterone Preterm Birth Patent
October 12, 2010
from Business Wire News Releases
Watson Reaches Settlement with Endo Over Opana® ER
October 07, 2010
from PR Newswire
Watson Confirms Azilect® Patent Challenge
October 05, 2010
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Watson, Moksha8 Form Marketing Partnership for Brazil, Mexico; Watson Makes Initial $30 Million Investment
October 04, 2010
Watson Investment Part of $61 Million Moksha8 Financing Read More
from PR Newswire
Watson to Present at the Jefferies 2010 Global SpecPharma & European Healthcare Conference
September 28, 2010
from PR Newswire
Analyst Research on Mylan and Watson Pharmaceuticals - Generic Drugs Makers Look Set For Breakthrough
September 21, 2010
from Marketwired News Releases
HRA Pharma and Watson Pharmaceuticals Expand Marketing Partnership for Novel Emergency Contraceptive to Canada
September 17, 2010
Agreement follows FDA approval of ella® in the U.S., where Watson will market the product Read More
from PR Newswire
Eden Biodesign Vaccine Expert to Speak at BioProcess International Conference & Exhibition
September 15, 2010
from Business Wire News Releases
Watson to Present at the Bank of America/Merrill Lynch Global Healthcare Conference
September 08, 2010
from PR Newswire
Watson's Generic Yasmin® Receives FDA Approval
September 07, 2010
from PR Newswire
Watson Confirms Combigan® Patent Challenge
September 07, 2010
- Paragraph IV Litigation Underway - Read More
from PR Newswire
Watson to Present at the Morgan Stanley Global Healthcare Unplugged Conference
September 01, 2010
from PR Newswire
Research Reports on Mylan and Watson Pharmaceuticals - Generic Drug Makers Striving Successfully
August 30, 2010
from Marketwired News Releases
Watson Plans Q4 2010 ella® (ulipristal acetate) Emergency Contraceptive Launch
August 13, 2010
from PR Newswire
Fitch Upgrades Watson Pharmaceuticals' IDR to 'BBB'; Outlook Stable
August 09, 2010
from Business Wire News Releases
Watson Q2 Net Revenue Climbs 29 Percent to $875 Million
August 05, 2010
- Second Quarter Adjusted Cash EPS of $0.83; 2010 GAAP EPS of $0.57 Read More
from PR Newswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here